2026 Summer Intern – Supply Chain at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Pursuing a degree (rising junior or rising senior) in business or supply chain, with a specific interest in supply chain
Ability to complete the entire 10-week program (from May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline to specified address)
Currently enrolled in an accredited U.S.-based college or university
Enrolled in an undergraduate (Bachelor’s), graduate, MBA, JD, PharmD, or PhD program
Legally authorized to work in the U.S. without a need for sponsorship/CPT/OPT now or in the future
At least 18 years of age prior to the scheduled start date
Must be available to complete virtual interviews with HR and hiring manager
Must successfully pass a drug screen and background check prior to start date
Must complete a final presentation at the end of the 10-week program (mandatory)
For Parsippany-based roles: Expected to work no less than 4 days at the site in Parsippany, New Jersey, on days in conjunction with assigned team; may work 1 day per week remotely
Application deadline is January 9, 2026

Responsibilities

Responsible for opex improvements in various areas of the manufacturing supply chain

Skills

Key technologies and capabilities for this role

Supply ChainInventory ForecastingReplenishment PlanningWarehousingProcurementSchedulingImport/Export

Questions & Answers

Common questions about this position

What is the work arrangement for this internship?

This role is based in Parsippany, New Jersey, and requires working no less than 4 days per week at the site, with the option to work 1 day remotely.

What are the educational requirements for this internship?

Candidates must be pursuing a degree as a rising junior or rising senior in business or supply chain, with a specific interest in supply chain, and maintain a cumulative 3.0 GPA or above.

What is the duration and time commitment for the internship?

The program runs for 10 weeks from May 26, 2026 to July 31, 2026, requiring 37.5 hours per week.

What is the application deadline and process for this position?

The application deadline is January 9, 2026, and candidates must mail an official college transcript to the specified address by the deadline, complete virtual interviews, and be available for a final presentation.

What compensation or benefits does Ferring offer for interns?

This information is not specified in the job description.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free